Sangamo Therapeutics
Patents, Design & Utilities
Last updated:
List of all Sangamo Therapeutics patents 110 in total
Status | Patent |
---|---|
Grant | Utility: FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks Filling date: 8 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: Liver-specific constructs and methods of use thereof Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Method of inactivating the IPK1 gene in corn Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Compositions for linking DNA-binding domains and cleavage domains Filling date: 8 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: ENGINEERED TARGET SPECIFIC NUCLEASES Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: Modulators of Chromosome 9 Open Reading Frame 72 Gene Expression and Uses Thereof Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Nuclease-mediated regulation of gene expression Filling date: 8 Sep 2025 Issue date: 20 Oct 2020 |
Application | Utility: COMPOSITIONS FOR LINKING DNA-BINDING DOMAINS AND CLEAVAGE DOMAINS Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INCREASING RNA ACTIVITY IN A CELL Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHOD FOR THE TREATMENT OF BETA-THALASSEMIA Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED CLEAVAGE AND RECOMBINATION Filling date: 8 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: TARGETED DELETION OF CELLULAR DNA SEQUENCES Filling date: 8 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR ENGINEERING IMMUNITY Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT AAV Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED SINGLE-STRANDED CLEAVAGE AND TARGETED INTEGRATION Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE I Filling date: 8 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: ENGINEERED CLEAVAGE HALF-DOMAINS Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Grant | Utility: Methods and compositions for targeted single-stranded cleavage and targeted integration Filling date: 8 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Methods and compositions for targeted cleavage and recombination Filling date: 8 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Targeted deletion of cellular DNA sequences Filling date: 8 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Methods and compositions for treating trinucleotide repeat disorders Filling date: 8 Sep 2025 Issue date: 12 May 2020 |
Grant | Utility: Artificial nucleases including engineered FokI cleavage half-domains Filling date: 8 Sep 2025 Issue date: 5 May 2020 |
Application | Utility: REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES Filling date: 8 Sep 2025 Issue date: 30 Apr 2020 |
Grant | Utility: Nuclease-mediated regulation of gene expression Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 |
Application | Utility: ENGINEERED GENETIC MODULATORS Filling date: 8 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS Filling date: 8 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING Filling date: 8 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: FAD3 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKS Filling date: 8 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODIFICATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE Filling date: 8 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: TARGETED DISRUPTION OF THE MHC CELL RECEPTOR Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INTEGRATION OF AN EXOGENOUS SEQUENCE WITHIN THE GENOME OF PLANTS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: ENZYMATIC ASSAYS FOR QUANTIFYING THERAPY IN SUBJECTS WITH MUCOPOLYSACCHARIDOSIS TYPE I OR II Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks Filling date: 8 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: ENGINEERED TARGET SPECIFIC BASE EDITORS Filling date: 8 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II Filling date: 8 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Regulation of gene expression using engineered nucleases Filling date: 8 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: Compositions for linking DNA-binding domains and cleavage domains Filling date: 8 Sep 2025 Issue date: 21 Jan 2020 |
Grant | Utility: FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks Filling date: 8 Sep 2025 Issue date: 7 Jan 2020 |
Application | Utility: HTT REPRESSORS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 2 Jan 2020 |
Grant | Utility: Targeted disruption of the MHC cell receptor Filling date: 8 Sep 2025 Issue date: 10 Dec 2019 |
Application | Utility: DELIVERY OF TARGET SPECIFIC NUCLEASES Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Utility: Delivery methods and compositions for nuclease-mediated genome engineering Filling date: 8 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: B-CELL ENGINEERING Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA Filling date: 8 Sep 2025 Issue date: 14 Nov 2019 |
Grant | Utility: Methods and compositions for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 12 Nov 2019 |
Application | Utility: TARGETED MODIFICATION OF MALATE DEHYDROGENASE Filling date: 8 Sep 2025 Issue date: 31 Oct 2019 |
Showing 50 to 100 of 110 patents.